9th Microbiome Movement Drug Development Summit
Evvnt Promotion / evvnt
Archivio
10.07.2024 - 12.07.2024 The Westin Copley Place, Boston, 10 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 AM - 4:15 PM
Temi della conferenza
As landmark Ferring and Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community.
The 9th Microbiome Movement Drug Development Summit returns as the industry's trusted, definitive forum for the global network of microbial therapeutic developers.
As landmark Ferring and Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community.
The 9th Microbiome Movement Drug Development Summit returns as the industry's trusted, definitive forum for the global network of microbial therapeutic developers.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2317343-3?pid=4832
Speakers: Ada Lam, Research Analyst, Beacon Microbiome, Adam Harvey, Associate Director - Clinical Research, Global Clinical and Translational Sciences, Ferring Pharmaceuticals, and more
URL:
Brochure: https://go.evvnt.com/2317343-3?pid=4832
Speakers: Ada Lam, Research Analyst, Beacon Microbiome, Adam Harvey, Associate Director - Clinical Research, Global Clinical and Translational Sciences, Ferring Pharmaceuticals, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2317343-2?pid=4832
Ms. Nandita Iyer
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
